Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI-Reference-Cited by-同舟云学术

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Published:2020-09 Issue:3 Volume:296 Page:564-572
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Lindenberg Liza^ORCID,Mena Esther,Turkbey Baris^ORCID,Shih Joanna H.^ORCID,Reese Sarah E.^ORCID,Harmon Stephanie A.^ORCID,Lim Ilhan,Lin Frank,Ton Anita,McKinney Yolanda L.,Eclarinal Philip^ORCID,Citrin Deborah E.^ORCID,Dahut William^ORCID,Madan Ravi^ORCID,Wood Bradford J.^ORCID,Krishnasamy Venkatesh^ORCID,Chang Richard,Levy Elliot,Pinto Peter,Eary Janet F.^ORCID,Choyke Peter L.^ORCID

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2020192018

Reference27 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy

3. Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

4. Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

5. 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Applications of PET/MR: Part II: Clinical Applications II;Canadian Association of Radiologists Journal;2024-06-05

2. Head-to-head comparison of prostate-specific membrane antigen positron emission tomography/computed tomography and multiparametric magnetic resonance imaging in the detection of biochemical recurrence of prostate cancer: a systematic review and meta-analysis;Clinical Radiology;2024-06

3. Diagnostic Accuracy of 18F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews;Seminars in Nuclear Medicine;2024-06

4. Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN;Oncotarget;2024-05-07

5. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy;Journal of Urology;2024-04